Introduction
Psychological distress, fatigue, perceived stigma and disordered eating are prevalent in IBD, yet multidimensional assessment using validated Patient-Reported Outcomes (PROs) is rarely performed in routine care.
Aims & Methods
Single-centre, cross-sectional study enrolling consecutive IBD outpatients (Crohn's disease [CD] or ulcerative colitis [UC]) at a tertiary referral centre between February and April 2026. Five validated PROs were administered: IBD Disk (disability, 0–100), FACIT-Fatigue Scale (0–52; higher = less fatigue), HADS (anxiety/depression, 0–21 each subscale), Perceived Stigma Scale for IBD (PSS-IBD; 0–80) and EDE-Q (eating disorder attitudes; 0–6). Clinical activity was assessed by Harvey-Bradshaw Index (CD) and partial Mayo score (UC). Multivariable linear regression (MLR) was performed for each PRO using predictors selected by univariate screening (p<0.10): age, sex, disease activity, BMI, disease duration, advanced therapy, surgery, comorbidities, psychiatric comorbidity, living situation, smoking. A pre-specified subanalysis in CD patients examined the role of disease phenotype (inflammatory B1 vs complicated B2/B3) on anxiety.
Results
159 patients were enrolled (CD 71, UC 80; 45% female; mean age 43.4±15.7 years; disease duration 13.2±9.2 years; 80% on advanced therapy); 151 had complete data for regression analyses. Despite 74% in clinical remission, fatigue was highly prevalent (93% FACIT-F <30; mean 13.6±9.4), depression was highly prevalent (67% HADS-D ≥11; mean 11.2±2.1) and clinically relevant anxiety was present in 62% (HADS-A ≥8; mean 8.5±2.6). Mean IBD Disk was 30.1±21.5; most impaired domains were energy (4.8/10), emotions (4.1/10) and sleep (3.7/10). Eating concern (EDE-Q >2.3) affected 16% of patients.
On MLR, higher IBD-related disability was independently associated with female sex (p=0.006) and greater disease activity (p=0.002; R²=0.16). Greater fatigue (lower FACIT-F) was independently associated with female sex (p=0.001), disease activity (p=0.009), absence of psychiatric comorbidity (p=0.022) and living alone (p=0.009; R²=0.23). Higher depression scores were independently associated with higher BMI (p=0.037) and younger age (p=0.026; R²=0.11). Eating concern was independently associated with BMI alone (p=0.001; R²=0.11).
In the overall cohort, neither anxiety nor perceived stigma were independently associated with clinical or demographic variables. In contrast, in a pre-specified subanalysis of CD patients (n=69), complicated disease phenotype (B2/B3 vs B1) was independently associated with greater anxiety, alongside disease activity (R²=0.19; phenotype p=0.048, disease activity p=0.023). Overall, all patients had at least one PRO above validated thresholds, and 38% exceeded thresholds on ≥3 domains.
Conclusion
In IBD outpatients at a tertiary referral centre, a high and multidimensional psychological burden was identified despite predominantly remission status. Disability and fatigue were independently associated with female sex and disease activity, while depression and eating concern were associated with BMI. Anxiety and perceived stigma were not explained by clinical variables in the overall cohort, although CD phenotype contributed to anxiety. These findings support the integration of multidimensional PRO screening into routine IBD care.
References
Neither anxiety nor perceived stigma were independently associated with any clinical or demographic variable in the overall cohort. However, in a pre-specified subanalysis restricted to CD patients (n=69), complicated disease phenotype (B2/B3 vs B1) was independently associated with greater anxiety alongside disease activity (R²=0.19; phenotype p=0.048, disease activity p=0.023). No patient had zero PROs above validated clinical thresholds, and 38% exceeded thresholds on ≥3 domains.